PortfoliosLab logoPortfoliosLab logo
IBIO vs. XBIT
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

IBIO vs. XBIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iBio, Inc. (IBIO) and XBiotech Inc. (XBIT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

IBIO vs. XBIT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IBIO
iBio, Inc.
1.04%-21.22%78.83%-84.59%-96.76%-47.71%320.00%-66.82%-58.14%-54.43%
XBIT
XBiotech Inc.
-2.09%-39.49%-1.25%13.96%-68.46%-17.46%-16.15%267.42%28.93%-61.07%

Fundamentals

EPS

IBIO:

-$0.44

XBIT:

-$0.96

Total Revenue (TTM)

IBIO:

$300.00K

XBIT:

$0.00

Gross Profit (TTM)

IBIO:

$11.00K

XBIT:

-$427.00K

EBITDA (TTM)

IBIO:

-$14.75M

XBIT:

-$27.00M

Returns By Period

In the year-to-date period, IBIO achieves a 1.04% return, which is significantly higher than XBIT's -2.09% return. Over the past 10 years, IBIO has underperformed XBIT with an annualized return of -51.79%, while XBIT has yielded a comparatively higher -11.73% annualized return.


IBIO

1D
2.63%
1M
-27.51%
YTD
1.04%
6M
136.71%
1Y
-50.13%
3Y*
-63.94%
5Y*
-70.09%
10Y*
-51.79%

XBIT

1D
-0.43%
1M
0.86%
YTD
-2.09%
6M
-11.36%
1Y
-22.52%
3Y*
-12.14%
5Y*
-30.80%
10Y*
-11.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBIO vs. XBIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBIO
IBIO Risk / Return Rank: 2929
Overall Rank
IBIO Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
IBIO Sortino Ratio Rank: 3636
Sortino Ratio Rank
IBIO Omega Ratio Rank: 3636
Omega Ratio Rank
IBIO Calmar Ratio Rank: 2121
Calmar Ratio Rank
IBIO Martin Ratio Rank: 2828
Martin Ratio Rank

XBIT
XBIT Risk / Return Rank: 2121
Overall Rank
XBIT Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
XBIT Sortino Ratio Rank: 2424
Sortino Ratio Rank
XBIT Omega Ratio Rank: 2424
Omega Ratio Rank
XBIT Calmar Ratio Rank: 1616
Calmar Ratio Rank
XBIT Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBIO vs. XBIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iBio, Inc. (IBIO) and XBiotech Inc. (XBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBIOXBITDifference

Sharpe ratio

Return per unit of total volatility

-0.37

-0.38

+0.01

Sortino ratio

Return per unit of downside risk

0.29

-0.22

+0.51

Omega ratio

Gain probability vs. loss probability

1.04

0.98

+0.06

Calmar ratio

Return relative to maximum drawdown

-0.60

-0.70

+0.11

Martin ratio

Return relative to average drawdown

-0.75

-1.17

+0.42

IBIO vs. XBIT - Sharpe Ratio Comparison

The current IBIO Sharpe Ratio is -0.37, which is comparable to the XBIT Sharpe Ratio of -0.38. The chart below compares the historical Sharpe Ratios of IBIO and XBIT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


IBIOXBITDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.37

-0.38

+0.01

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.46

-0.48

+0.03

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.33

-0.15

-0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

-0.23

0.00

Correlation

The correlation between IBIO and XBIT is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

IBIO vs. XBIT - Dividend Comparison

Neither IBIO nor XBIT has paid dividends to shareholders.


TTM20252024202320222021
IBIO
iBio, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
XBIT
XBiotech Inc.
0.00%0.00%0.00%0.00%0.00%22.46%

Drawdowns

IBIO vs. XBIT - Drawdown Comparison

The maximum IBIO drawdown since its inception was -100.00%, which is greater than XBIT's maximum drawdown of -92.67%. Use the drawdown chart below to compare losses from any high point for IBIO and XBIT.


Loading graphics...

Drawdown Indicators


IBIOXBITDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-92.67%

-7.33%

Max Drawdown (1Y)

Largest decline over 1 year

-86.09%

-39.43%

-46.66%

Max Drawdown (5Y)

Largest decline over 5 years

-99.93%

-87.21%

-12.72%

Max Drawdown (10Y)

Largest decline over 10 years

-99.98%

-90.72%

-9.26%

Current Drawdown

Current decline from peak

-99.99%

-91.38%

-8.61%

Average Drawdown

Average peak-to-trough decline

-86.54%

-69.78%

-16.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

68.87%

23.84%

+45.03%

Volatility

IBIO vs. XBIT - Volatility Comparison

iBio, Inc. (IBIO) has a higher volatility of 31.99% compared to XBiotech Inc. (XBIT) at 7.77%. This indicates that IBIO's price experiences larger fluctuations and is considered to be riskier than XBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


IBIOXBITDifference

Volatility (1M)

Calculated over the trailing 1-month period

31.99%

7.77%

+24.22%

Volatility (6M)

Calculated over the trailing 6-month period

95.92%

40.36%

+55.56%

Volatility (1Y)

Calculated over the trailing 1-year period

135.26%

59.87%

+75.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

153.63%

64.08%

+89.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

156.81%

75.92%

+80.89%

Financials

IBIO vs. XBIT - Financials Comparison

This section allows you to compare key financial metrics between iBio, Inc. and XBiotech Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00M2.00M3.00M4.00M5.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober00
(IBIO) Total Revenue
(XBIT) Total Revenue
Values in USD except per share items